(Q36245680)

English

Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

0 references

dermatomyositis

0 references

author name string

Fumihito Suzuki

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Tetsuo Kubota

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Yasunari Miyazaki

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Kinya Ishikawa

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Masashi Ebisawa

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Shunsei Hirohata

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Takashi Ogura

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Hidehiro Mizusawa

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Toshio Imai

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Nobuyuki Miyasaka

10

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Toshihiro Nanki

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

6 March 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Arthritis Research and Therapy

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

R48

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Characterization of synergistic induction of CX3CL1/fractalkine by TNF-alpha and IFN-gamma in vascular endothelial cells: an essential role for TNF-alpha in post-transcriptional regulation of CX3CL1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Inhibition of CX3CL1 (fractalkine) improves experimental autoimmune myositis in SJL/J mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

International consensus on preliminary definitions of improvement in adult and juvenile myositis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Polymyositis-dermatomyositis-associated interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

A new class of membrane-bound chemokine with a CX3C motif

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Polymyositis, dermatomyositis and inclusion-body myositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Polymyositis and dermatomyositis (second of two parts)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

1 October 2017

T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1186%2FAR3761

21 January 2018

Serum TARC/CCL17 levels are increased in dermatomyositis associated with interstitial lung disease

1 reference

https://api.crossref.org/works/10.1186%2FAR3761

21 January 2018

Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.

1 reference

https://api.crossref.org/works/10.1186%2FAR3761

21 January 2018

Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis.

1 reference

https://api.crossref.org/works/10.1186%2FAR3761

21 January 2018

Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446414

22 September 2018

Reliability and validity of the myositis disease activity assessment tool

1 reference

https://api.crossref.org/works/10.1186%2FAR3761

21 January 2018

International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1186%2FAR3761

21 January 2018

Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22394569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interstitial lung disease in polymyositis and dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22394569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CX3C chemokine fractalkine in allergic asthma and rhinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22394569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine expression profile in idiopathic inflammatory myopathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22394569

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36245680&oldid=2198439721"